More Like this

1. How drug onset rate and duration of action affect drug forgiveness

   https://doi.org/10.1007/s10928-023-09897-1  

   Clark, Elias D.; Lawley, Sean D. (January 2024, Journal of Pharmacokinetics and Pharmacodynamics)
2. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding

   https://doi.org/10.1371/journal.pcbi.1008040  

   Chen, Huiyuan; Cheng, Feixiong; Li, Jing (July 2020, PLOS Computational Biology)

   Schlessinger, Avner (Ed.)
3. Multitask Dyadic Prediction and Its Application in Prediction of Adverse Drug-Drug Interaction

   Jin, B.; Yang, H.; Xiao, C.; Zhang, P.; Wei, X.; Wang, F. (February 2017, Proceedings of the Thirty-First AAAI Conference on Artificial Intelligence)
4. Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity

   https://doi.org/10.7554/eLife.69032  

   Feder, Alison F; Harper, Kristin N; Brumme, Chanson J; Pennings, Pleuni S (September 2021, eLife)

   Triple-drug therapies have transformed HIV from a fatal condition to a chronic one. These therapies should prevent HIV drug resistance evolution, because one or more drugs suppress any partially resistant viruses. In practice, such therapies drastically reduced, but did not eliminate, resistance evolution. In this article, we reanalyze published data from an evolutionary perspective and demonstrate several intriguing patterns about HIV resistance evolution - resistance evolves (1) even after years on successful therapy, (2) sequentially, often via one mutation at a time and (3) in a partially predictable order. We describe how these observations might emerge under two models of HIV drugs varying in space or time. Despite decades of work in this area, much opportunity remains to create models with realistic parameters for three drugs, and to match model outcomes to resistance rates and genetic patterns from individuals on triple-drug therapy. Further, lessons from HIV may inform other systems. 

   more » « less
5. Transcriptome signature of cell viability predicts drug response and drug interaction in Mycobacterium tuberculosis

   https://doi.org/10.1016/j.crmeth.2021.100123  

   Srinivas, Vivek; Ruiz, Rene A.; Pan, Min; Immanuel, Selva Rupa; Peterson, Eliza J.R.; Baliga, Nitin S. (December 2021, Cell Reports Methods)